iRhythm, best known for its Zio cardiac monitoring wearables, is moving to expand well beyond its 14-day-patch roots by acquiring wearable biosensor company VitalConnect for $287.5M. iRhythm’s strategic logic is about widening what it can monitor and where. VitalConnect’s FDA-cleared monitoring platform already spans several cardiac modalities plus multi-vitals capabilities built for hospital and remote-care […] The post iRhythm Expands MCT Footprint with VitalConnect Acquisition appeared first on Cardiac Wire .